Epidemiological characteristics of acute pulmonary thromboembolism in Japan

International Angiology

Volumn 22, Issue 1, 2003, Pages 50-54

  Yamada, N ^a   Nakamura, M ^a   Ishikura, K ^a   Ota, M ^a   Yazu, T ^a   Hiraoka, N ^a   Tanaka, H ^a   Ito, M ^a   Fujioka, H ^a   Isaka, N ^a   Nakano, T ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Japan; Pulmonary embolism, epidemiology; Risk factors; Thromboembolism; Thrombophilia; Venous thrombosis

Indexed keywords

ANTITHROMBIN III; PROTEIN C; PROTEIN S;

ADULT; AGED; ANTITHROMBIN III DEFICIENCY; ARTICLE; CANCER; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DIGESTIVE SYSTEM CANCER; FEMALE; GROUPS BY AGE; GYNECOLOGIC CANCER; GYNECOLOGY; HOSPITAL ADMISSION; HUMAN; IMMOBILIZATION; INTERNAL MEDICINE; JAPAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSTETRICS; ORTHOPEDICS; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; SEX RATIO; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOPHILIA; URINARY TRACT CANCER;

ACUTE DISEASE; AGE FACTORS; AGED; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THROMBOPHILIA;

EID: 0038724624     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gore I, Hirst AE, Tanaka K. Myocardial infarction and thrombosis. Arch Intern Med 1964;113:323-30.
2. Nakamura M. Current status of pulmonary thromboembolism in Japan. Nippon Jpn J Thromb Hemost 2001;12: 450-9.
3. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93.
4. Kumasaka N, Sakuma M, Shirato K. Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 1999;63: 439-41.
5. Itou S. Clinico-pathological studies on pulmonary thromboembolism. Mie-Igaku 1982;25:586-97.
6. Nakamura M, Fujioka H, Yamada N, Sakuma M, Okada O, Nakanishi N et al. Clinical characteristics of acute pulmonary thromboembolism of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001;24:132-8.
7. Nakamura M, Okada O, Sakuma M, Nakanishi N, Miyahara Y, Yamada N et al. Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared to acute pulmonary thromboembolism: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Circ J 2002;66:257-60.
8. Ota M, Nakamura M, Yamada N, Yazu T, Ishikura K, Hiraoka N et al. Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure. Heart Vessels 2002;17:7-11.
9. Coon WW. Risk factors in pulmonary embolism. Surg Gynecol Obstet 1976;143:385-90.
10. Goldhaber SZ, Savage DD, Garrison RJ, Castely WP, Kannel WB, McNamara PM et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983;74: 1023-8.
11. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992;152:1660-4.
12. Seki T, Okayama H, Kumagai T, Kumasaka N, Sakuma M, Isoyama S et al. Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism. Heart Vessels 1998;13:195-8.
13. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000;85:1334-7.
14. Kumasaka N, Sakuma M, Shirato K. Clinical features and predictors of in-hospital mortality in patients with acute and chronic pulmonary thromboembolism. Intern Med 2000;39:1038-43.
15. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators. Chest 1990;97:528-33.
16. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995;346:1575-82.
17. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997;277:642-5.
18. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861-6.
19. Piccioli A, Prandoni P, Goldhaber SZ. Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. Am Heart J 1996;132: 1010-4.
20. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals from the council on thrombosis (in consultation with the council on cardiovascular radiology), American Heart Association. Circulation 1996;93:2212-45.
21. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr et al. Prevention of venous thromboembolism. Chest 2001; 119Suppl:132S-75.
22. Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001;20:1-37.
23. Giuntini C, Di Ricco G, Marini C, Melillo E, Palla A. Pulmonary embolism: epidemiology. Chest 1995;107:3S-9.
24. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
25. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
26. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
27. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685-91.
28. Ferrari E, Baudouy M, Cerboni P, Tibi T, Guigner A, Leonetti J et al. Clinical epidemiology of venous thromboembolic disease. Results of a French Multicentre Regitry. Eur Heart J 1997;18:685-91.